211 related articles for article (PubMed ID: 25385001)
1. Preferential, enhanced breast cancer cell migration on biomimetic electrospun nanofiber 'cell highways'.
Nelson MT; Short A; Cole SL; Gross AC; Winter J; Eubank TD; Lannutti JJ
BMC Cancer; 2014 Nov; 14():825. PubMed ID: 25385001
[TBL] [Abstract][Full Text] [Related]
2. CXCR4/CXCL12 participate in extravasation of metastasizing breast cancer cells within the liver in a rat model.
Wendel C; Hemping-Bovenkerk A; Krasnyanska J; Mees ST; Kochetkova M; Stoeppeler S; Haier J
PLoS One; 2012; 7(1):e30046. PubMed ID: 22253872
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
4. CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis.
Sun Y; Mao X; Fan C; Liu C; Guo A; Guan S; Jin Q; Li B; Yao F; Jin F
Tumour Biol; 2014 Aug; 35(8):7765-73. PubMed ID: 24810923
[TBL] [Abstract][Full Text] [Related]
5. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
6. CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways.
Sobolik T; Su YJ; Wells S; Ayers GD; Cook RS; Richmond A
Mol Biol Cell; 2014 Mar; 25(5):566-82. PubMed ID: 24403602
[TBL] [Abstract][Full Text] [Related]
7. COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration.
Boudot A; Kerdivel G; Lecomte S; Flouriot G; Desille M; Godey F; Leveque J; Tas P; Le Dréan Y; Pakdel F
BMC Cancer; 2014 Jun; 14():407. PubMed ID: 24906407
[TBL] [Abstract][Full Text] [Related]
8. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.
Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ
Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985
[TBL] [Abstract][Full Text] [Related]
9. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.
Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J
Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780
[TBL] [Abstract][Full Text] [Related]
10. Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins.
Castelló-Cros R; Khan DR; Simons J; Valianou M; Cukierman E
BMC Cancer; 2009 Mar; 9():94. PubMed ID: 19323811
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.
Wendt MK; Cooper AN; Dwinell MB
Oncogene; 2008 Feb; 27(10):1461-71. PubMed ID: 17724466
[TBL] [Abstract][Full Text] [Related]
13. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
14. Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration.
Pirani E; Paparoditis P; Pecoraro M; Danelon G; Thelen M; Cecchinato V; Uguccioni M
Front Immunol; 2024; 15():1358800. PubMed ID: 38803493
[TBL] [Abstract][Full Text] [Related]
15. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
[TBL] [Abstract][Full Text] [Related]
16. Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer.
Kang H; Watkins G; Parr C; Douglas-Jones A; Mansel RE; Jiang WG
Breast Cancer Res; 2005; 7(4):R402-10. PubMed ID: 15987445
[TBL] [Abstract][Full Text] [Related]
17. In vivo "MRI phenotyping" reveals changes in extracellular matrix transport and vascularization that mediate VEGF-driven increase in breast cancer metastasis.
Pathak AP; McNutt S; Shah T; Wildes F; Raman V; Bhujwalla ZM
PLoS One; 2013; 8(5):e63146. PubMed ID: 23650550
[TBL] [Abstract][Full Text] [Related]
18. Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).
Alam F; Al-Hilal TA; Park J; Choi JU; Mahmud F; Jeong JH; Kim IS; Kim SY; Hwang SR; Byun Y
Biomaterials; 2016 Apr; 86():56-67. PubMed ID: 26890038
[TBL] [Abstract][Full Text] [Related]
19. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
20. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
Hernandez L; Magalhaes MA; Coniglio SJ; Condeelis JS; Segall JE
Breast Cancer Res; 2011; 13(6):R128. PubMed ID: 22152016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
